Connecticut

Connecticut has solidified its position as a premier global life sciences hub, strategically located within the high-density Northeast corridor between New York and Boston.

The state is best known for its "Bioscience Connecticut" initiative, which has fueled a surge in biotechnology startups and established a world-class infrastructure for pharmaceutical R&D.

Anchored by Ivy League excellence at Yale University and the clinical research powerhouse of UConn Health, the ecosystem excels in genomic medicine, protein degradation therapies and bioscience innovation.

Connecticut's medical device sector is a national leader, driven by giants like Medtronic and a robust supply chain specializing in precision manufacturing and healthcare technology.

The state ranks among the highest in the US for NIH funding per capita and bioscience patents, reflecting a culture of intense academic research and commercialization. Strategic investments in incubator spaces and wet labs, such as those in New Haven's Downtown Crossing, provide a fertile ground for early-stage biopharma companies.

Furthermore, the integration of artificial intelligence in healthcare and digital health platforms is transforming patient outcomes across the state's integrated hospital networks.

With a highly educated STEM workforce and competitive R&D tax credits, Connecticut offers a compelling value proposition for global life sciences investment.